IDiyas

For the Inventor, By the Inventor

Arlington, MA, United States of America

Elaine Chungmin Lee

USPTO Granted Patents = 10 

 

 

Average Co-Inventor Count = 7.0

ph-index = 9

Forward Citations = 465(Granted Patents)


Location History:

  • Cambridge, MA (US) (2013 - 2014)
  • Arlington, MA (US) (2014 - 2023)

Company Filing History:

goldMedal10 out of 1,149 
 
Vertex Pharmaceuticals, Inc.
 patents

Years Active: 2013-2023

Loading Chart...
Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents
1. 11578062 - Solid forms of (R)-1(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide (2023-02-14),
2. 10906891 - Solid forms of (R)-1(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide (2021-02-02),
3. 10081621 - Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide (2018-09-25),
4. 10071979 - Process of producing cycloalkylcarboxamido-indole compounds (2018-09-11),
5. 9051303 - [object Object] (2015-06-09),
6. 9035072 - Process of producing cycloalkylcarboxamido-indole compounds (2015-05-19),
7. 8884018 - Process for preparing modulators of cystic fibrosis transmembrane conductance regulator (2014-11-11),
8. 8802868 - Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxo1-5-yl)-N-(1-(2,3-dihydroxypropyl-6-fluoro-2-(1-hydroxy-2-methylpropan2-yl)-1H-Indol-5-yl)-Cyclopropanecarboxamide (2014-08-12),
9. 8754222 - Process for preparing modulators of cystic fibrosis transmembrane conductance regulator (2014-06-17),
10. 8344147 - Process for preparing modulators of cystic fibrosis transmembrane conductance regulator (2013-01-01),

Title: Elaine Chungmin Lee: Innovator in Pharmaceutical Chemistry

Introduction

Elaine Chungmin Lee is a prominent inventor based in Arlington, MA (US). She has made significant contributions to the field of pharmaceutical chemistry, holding a total of 10 patents. Her work focuses on the development of innovative solid forms of pharmaceutical compounds.

Latest Patents

Among her latest patents is a groundbreaking invention related to solid forms of (R)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide. This invention pertains to the pharmaceutical compositions of this compound in substantially crystalline form (Form A) or amorphous form, along with methods of treatment utilizing these compositions.

Career Highlights

Elaine is currently employed at Vertex Pharmaceuticals, Inc., where she continues to advance her research and development efforts. Her innovative work has positioned her as a key figure in the pharmaceutical industry, contributing to the creation of effective treatments.

Collaborations

Elaine has collaborated with notable coworkers, including Robert Michael Hughes and Benjamin Joseph Littler, enhancing the impact of her research through teamwork and shared expertise.

Conclusion

Elaine Chungmin Lee exemplifies the spirit of innovation in pharmaceutical chemistry, with her patents paving the way for new treatment options. Her contributions are invaluable to the field and highlight the importance of research and collaboration in advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…